Welcome to My Blog
Here is a masonry blog layout with no sidebarAirlines in India seek $1.5 bn in interest-free credit line, says govt
The government is engaged with aircraft lessors and financiers to ensure there is no premature withdrawal of planes, Civil Aviation Minister Hardeep Singh Puri said. Local traffic has slumped almost 80 per cent to just 12 million passengers in the five months to July 31, eroding airline revenues, he said.
Close to 3 million jobs in aviation and related industries as well as more than $11 billion in revenue could be lost in India this year because of the pandemic according to the International Air Transport Association.
Nifty50 ETFs’ assets base crosses Rs 1 trn, asset under management Rs 2 trn
“We are encouraged by the investors’ continued confidence demonstrated through their participation in ETFs linked to Nifty 50 and other Nifty Indices…NSE will continue to actively promote ETFs to retail investors through multiple channels,” NSE Managing Director and Chief Executive Officer Vikram Limaye said.
Centre approved anti-viral medicines to treat COVID-19 patients, says SC
The top court was hearing a plea seeking registration of an FIR by the CBI against ten Indian pharmaceutical firms for manufacturing and selling these two medicines for treating COVID-19 patients allegedly without valid licences.
A bench comprising Chief Justice S A Bobde and Justices A S Bopanna and V Ramasubramanian referred to the New Drugs and Clinical Trials Rules, 2018 and said these medicines have been permitted by the government for using in treatment of novel coronavirus patients.
India’s coronavirus cases jump by daily record of 97,894
The COVID-19 case fatality rate due to the coronavirus infection was recorded at 1.63 per cent.
There are 10,09,976 active cases of COVID-19 in the country which comprises 19.73 per cent of the total caseload, the data stated.
With 5.12 million cases in all, India is the world’s second-worst affected country, and trails only the United States, which has a caseload of around 6.6 million
Global coronavirus cases to soon surpass 30 million: Reuters tally
The official number of global coronavirus cases is now more than five times the number of severe influenza illnesses recorded annually, according to World Health Organization data.
Around the world, there have been almost 1 million deaths, considered a lagging indicator given the two-week incubation period of the virus. That has well exceeded the upper range of 290,000 to 650,000 annual deaths linked to influenza.
Pandemic’s ‘great reset’ makes energy firms invest more in renewables: executives
Reeling from the onset of the pandemic, global oil consumption shrank by more than 20% in the second quarter and prices hit their lowest in decades, making companies rethink how fast they should make the transition away from reliance on oil and gas.
“Everyone’s talking about this great reset . What do we need to do to survive this?” Arif Mahmood, Petronas’ executive vice president and CEO of downstream, said at the virtual Platts APPEC 2020.
“Energy transition will be pushed forward much faster,” he concluded.
China’s Anbang Insurance Group to apply to disband, liquidate
After the Anbang take-over, China has tightened regulations on the country’s financial holdings companies to defuse risks accumulated by a group of non-financial firms that it says expanded blindly into the financial sector.
On Sunday, the People’s Bank of China (PBOC) issued related new rules, setting requirements on registered capital, total assets, and assets under management on eligible financial holdings firms.
Parliament passes bill to give statutory status to aviation regulators
Forecasts of heavy rains raise fear for summer crops in India
Novavax aims for 2 billion COVID-19 vaccine doses with expanded India deal
Novavax’s vaccine is currently in mid-stage trials after an early-stage study showed it produced high levels of antibodies against the novel coronavirus. The company plans to begin late-stage trials in the third quarter.Last month, Novavax said it will supply 60 million doses of its coronavirus vaccine candidate to the UK beginning as early as the first quarter of 2021.
Tech, healthcare mega deals boost virus-stricken M&A market
Technology and healthcare have historically the most active M&A sectors. But many companies in this sector have also fared better in the downturn, either because their offerings are accelerating the transition to digital workplaces and big data, or because they are benefiting from increased investment and spending on healthcare.
Civil aviation recovery to be faster due to market size: Airbus India Prez
India’s role in production of Covid-19 vaccine critical: Bill Gates
“We’ve been brokering the idea of taking a vaccine and manufacturing it in India, even if it comes from AstraZeneca, Oxford or Novavax or Johnson & Johnson. We’ve publicly talked about the arrangement where a Serum will be able to make very high volume of the AstraZeneca and the Novavax vaccine,” said Gates.
40 lakh people kept under surveillance as part of COVID contact-tracing Centre
Victory for UK firms in court battle over COVID-19 BI insurance claims
UK High Court rules in policyholders’ favour in landmark business insurance case
Some 370,000 firms which lost earnings as a result of lockdown could expect up to £1.2billion in damages
However, insurers are expected to appeal the decision – meaning firms will likely have to wait months before seeing any payout
COVID-19 tally in India breaches 48-lakh mark; death toll climbs 79,722
The COVID-19 case fatality rate due to the coronavirus infection has further dropped to 1.64 per cent.
There are 9,86,598 active cases of COVID-19 in the country, while 37,80,107 people have recovered, the data stated.
India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23 and it went past 40 lakh on September 5.
According to the ICMR, a cumulative total of 5,72,39,428 samples have been tested up to September 13 with 9,78,500 samples being tested on Sunday.
Asia offers more flu shots to head off COVID-19 complications
WHO head urges rich nations to join vaccine scheme by Friday deadline
So far, 92 lower-income nations are seeking assistance via the COVAX facility, part of the WHO’s ACT Accelerator to boost development of vaccines, therapeutics and diagnostics to combat the pandemic. Some 80 higher-income nations have expressed interest, but many must still confirm their intention to join by the end of this week.
“If people in low- and middle-income countries miss out on vaccines, the virus will continue to kill and the economic recovery globally will be delayed,” WHO Director General Tedros Adhanom Ghebreyesus told a WHO regional event for Europe that was broadcast virtually.
“Financial and political investments in preparedness have been insufficient, and we are all paying the price,” said the report by The Global Preparedness Monitoring Board (GPMB).